Transmembrane Helical Domain of the Cannabinoid CB1 Receptor

被引:27
|
作者
Shim, Joong-Youn [1 ]
机构
[1] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC USA
基金
美国国家科学基金会;
关键词
PROTEIN-COUPLED-RECEPTOR; MOLECULAR-DYNAMICS SIMULATION; INTERNAL WATER-MOLECULES; MEMBRANE ENVIRONMENT; SIGNAL-TRANSDUCTION; SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; RHODOPSIN FAMILY; ACTIVATION;
D O I
10.1016/j.bpj.2008.12.3934
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Brain cannabinoid (CB1) receptors are G-protein coupled receptors and belong to the rhodopsin-like subfamily. A homology model of the inactive state of the CB, receptor was constructed using the x-ray structure Of beta(2)-adrenergic receptor (beta(2)AR) as the template. We used 105 ns duration molecular-dynamics simulations of the CB1 receptor embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer to gain some insight into the structure and function of the CB1 receptor. As judged from the root mean-square deviations combined with the detailed structural analyses, the helical bundle of the CB1 receptor appears to be fully converged in 50 ns of the simulation. The results reveal that the helical bundle structure of the CB1 receptor maintains a topology quite similar to the x-ray structures of G-protein coupled receptors overall. It is also revealed that the CB1 receptor is stabilized by the formation of extensive, water-mediated H-bond networks, aromatic stacking interactions, and receptor-lipid interactions within the helical core region. It is likely that these interactions, which are often specific to functional motifs, including the S(N)LAxAD, D(E)RY, CWxP, and NPxxY motifs, are the molecular constraints imposed on the inactive state of the CB1 receptor. It appears that disruption of these specific interactions is necessary to release the molecular constraints to achieve a conformational change of the receptor suitable for G-protein activation.
引用
收藏
页码:3251 / 3262
页数:12
相关论文
共 50 条
  • [1] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    [J]. DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [2] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
  • [3] CB1 cannabinoid receptor antagonists
    Barth, F
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
  • [4] CB1 cannabinoid receptor ligands
    Thakur, GA
    Nikas, SP
    Makriyannis, A
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
  • [5] The Cannabinoid CB1 Receptor in Schizophrenia
    Borgan, Faith
    Kokkinou, Michelle
    Howes, Oliver
    [J]. BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
  • [6] Voltage dependence of the cannabinoid CB1 receptor
    Goldberger, Esty
    Tauber, Merav
    Ben-Chaim, Yair
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Internalization and recycling of the CB1 cannabinoid receptor
    Hsieh, C
    Brown, S
    Derleth, C
    Mackie, K
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) : 493 - 501
  • [8] Allosteric Modulation of Cannabinoid CB1 Receptor
    Ross, Ruth A.
    Baillie, Gemma L.
    Pertwee, Roger G.
    [J]. FASEB JOURNAL, 2012, 26
  • [9] Allosteric modulation of the cannabinoid CB1 receptor
    Price, MR
    Baillie, GL
    Thomas, A
    Stevenson, LA
    Easson, M
    Goodwin, R
    McLean, A
    McIntosh, L
    Goodwin, G
    Walker, G
    Westwood, P
    Marrs, J
    Thomson, F
    Cowley, P
    Christopoulos, A
    Pertwee, RG
    Ross, RA
    [J]. MOLECULAR PHARMACOLOGY, 2005, 68 (05) : 1484 - 1495
  • [10] Signal transduction of the CB1 cannabinoid receptor
    Turu, Gabor
    Hunyady, Laszlo
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2010, 44 (02) : 75 - 85